VYNT
Vyant Bio, Inc. Common Stock
VYNT
VYNT
Delisted
VYNT was delisted on the 12th of May, 2023.
17 hedge funds and large institutions have $222K invested in Vyant Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11K | |
| 2 | +$7.09K | |
| 3 | +$5.81K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.86K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.51K |
Top Sellers
| 1 | -$113K | |
| 2 | -$24K | |
| 3 | -$17K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$12K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$12K |